Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for cognitive symptoms in functional cognitive disorder
IRCT20250818066898N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Functional Cognitive Disorder (FCD) comparing Bupropion group with Placebo group (2 arms). Primary endpoints: Change in MoCA score, Change in Wechsler test performance and 5 more. Started Nov 2025; status: completed.
02
Drugs
bupropion
03
Conditions
Functional Cognitive Disorder (FCD)
Beyond the preview
Go deeper on IRCT20250818066898N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250818066898N1.